# Infantile-Onset Vanishing White Matter Disease in an Azerbaijani Infant With a Homozygous EIF2B5 p.(Arg195His) Variant

**Authors:** Cavid Isayev, Ilaha Haciyeva, Emil Hasanov, Fidan Hasanova, Parviz Samadov

PMC · DOI: 10.7759/cureus.103917 · Cureus · 2026-02-19

## TL;DR

A young Azerbaijani infant with a rare genetic disorder showed severe neurological symptoms after a fever, highlighting the importance of early genetic testing.

## Contribution

This case presents a novel clinical manifestation of infantile-onset vanishing white matter disease with a specific EIF2B5 mutation.

## Key findings

- The infant exhibited subacute VWM disease following a febrile illness.
- A homozygous EIF2B5 p.Arg195His variant was identified through genetic testing.
- MRI findings were consistent with advanced vanishing white matter disease.

## Abstract

An eight-month-old Azerbaijani male infant, born to consanguineous (first-cousin) parents, presented with developmental regression and daily seizures following a febrile illness. He achieved head control at six months (delayed). During the same month, a rotavirus infection (fever, vomiting, and diarrhea) precipitated focal and generalized seizures. Neurological examination at eight months demonstrated severe hypotonia, hyperreflexia, and markedly reduced voluntary movements, with preserved visual and auditory responses. Brain MRI showed diffuse supra- and infratentorial white matter T1 hypointensity and marked T2 hyperintensity, with loss of subcortical U-fibers and deep white matter fluid-attenuated inversion recovery hypointensity consistent with rarefaction/degeneration, while the basal ganglia and cerebral cortex were relatively spared, an imaging pattern highly suggestive of advanced vanishing white matter (VWM) disease. Genetic testing identified a homozygous EIF2B5 c.584G>A (p.Arg195His) variant, supporting the diagnosis. This case illustrates subacute infantile VWM with stressor-related neurologic deterioration, hypotonia, and refractory seizures, underscoring the value of early molecular diagnosis in infants with suspected leukodystrophy.

## Linked entities

- **Genes:** EIF2B5 (eukaryotic translation initiation factor 2B subunit epsilon) [NCBI Gene 8893]
- **Diseases:** vanishing white matter disease (MONDO:0800448), rotavirus infection (MONDO:0005194)

## Full-text entities

- **Genes:** ARHGEF2 (Rho/Rac guanine nucleotide exchange factor 2) [NCBI Gene 9181] {aka GEF, GEF-H1, GEFH1, LFP40, Lfc, NEDMHM}, EIF2B1 (eukaryotic translation initiation factor 2B subunit alpha) [NCBI Gene 1967] {aka EIF2B, EIF2BA, EIF2Balpha, VWM1}, EIF2B5 (eukaryotic translation initiation factor 2B subunit epsilon) [NCBI Gene 8893] {aka CACH, CLE, EIF-2B, EIF2Bepsilon, LVWM, VWM5}, EIF2A (eukaryotic translation initiation factor 2A) [NCBI Gene 83939] {aka CDA02, EIF-2A, MST089, MSTP004, MSTP089}
- **Diseases:** edema (MESH:D004487), cystic degeneration (MESH:D018297), optic atrophy (MESH:D009896), head trauma (MESH:D006259), febrile gastroenteritis (MESH:D005759), spasticity (MESH:D009128), trauma (MESH:D014947), matter rarefaction (MESH:D000073436), status epilepticus (MESH:D013226), vomiting (MESH:D014839), placental abruption (MESH:D000037), hyperreflexia (MESH:D012021), autosomal recessive disorder (MESH:D030342), Seizure (MESH:D012640), neurological decline (MESH:D009461), Febrile illness (MESH:D005334), cerebellar involvement (MESH:D002526), loss of motor skills (MESH:D019957), T2 (MESH:C535434), diarrhea (MESH:D003967), CACH (MESH:D056784), autosomal recessive leukodystrophy (MESH:D007966), cerebello-spastic (MESH:C536293), respiratory failure (MESH:D012131), febrile (MESH:D000071072), hypoxic (MESH:D002534), febrile infections (MESH:D007239), ischemic injury (MESH:D017202), myoclonic jerks (MESH:D009207), dysmyelination (MESH:D003711), Appendicular ataxia (MESH:D001259), mitochondrial encephalopathy (MESH:C538525), cerebellar ataxia (MESH:D002524), axial hypotonia (MESH:D009123), Epilepsy (MESH:D004827), corpus callosum abnormalities (MESH:D061085), neurologic deterioration (MESH:D009422), motor impairment (MESH:D000068079), developmental delay (MESH:D002658), rotavirus gastroenteritis (MESH:D012400), intrauterine fetal demise (MESH:D005313), gait ataxia (MESH:D020234)
- **Chemicals:** coenzyme Q10 (MESH:C024989), lactate (MESH:D019344), clobazam (MESH:D000078306), ammonia (MESH:D000641), oxygen (MESH:D010100), GTP (MESH:D006160), GDP (MESH:D006153), acylcarnitine (MESH:C116917), valproate (MESH:D014635), amino acids (MESH:D000596), proton (MESH:D011522), L-carnitine (MESH:D002331), organic acids (-), lacosamide (MESH:D000078334), levetiracetam (MESH:D000077287)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rotavirus (genus) [taxon 10912]
- **Mutations:** p.(Arg191His), c.584G>A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12919735/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12919735/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12919735/full.md

---
Source: https://tomesphere.com/paper/PMC12919735